Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
85.55
+0.12 (0.14%)
Nov 22, 2024, 4:00 PM EST - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Haemonetics stock have an average target of 107.88, with a low estimate of 85 and a high estimate of 125. The average target predicts an increase of 26.10% from the current stock price of 85.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Haemonetics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $112 | Strong Buy | Reiterates | $112 | +30.92% | Nov 15, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +26.24% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $120 | Buy → Strong Buy | Upgrades | $120 | +40.27% | Nov 8, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +26.24% | Sep 23, 2024 |
| CL King | CL King | Strong Buy Initiates $116 | Strong Buy | Initiates | $116 | +35.59% | Sep 13, 2024 |
Financial Forecast
Revenue This Year
1.41B
from 1.31B
Increased by 7.71%
Revenue Next Year
1.48B
from 1.41B
Increased by 4.89%
EPS This Year
4.63
from 2.29
Increased by 102.38%
EPS Next Year
5.38
from 4.63
Increased by 16.07%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.5B | 1.6B | 1.8B | |
| Avg | 1.4B | 1.5B | 1.6B | |
| Low | 1.4B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 12.5% | 14.3% | 23.2% | |
| Avg | 7.7% | 4.9% | 8.8% | |
| Low | 4.1% | -1.8% | 1.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.89 | 6.04 | 7.81 | |
| Avg | 4.63 | 5.38 | 6.34 | |
| Low | 4.45 | 4.94 | 5.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 113.7% | 30.3% | 45.2% | |
| Avg | 102.4% | 16.1% | 17.9% | |
| Low | 94.3% | 6.6% | 5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.